Skip to Content
Merck
CN

Development of lipopeptides for inhibiting 20S proteasomes.

Bioorganic & medicinal chemistry letters (2006-04-25)
Nicolas Basse, David Papapostolou, Maurice Pagano, Michèle Reboud-Ravaux, Elise Bernard, Anne-Sophie Felten, Régis Vanderesse
ABSTRACT

Proteasomes are responsible for the cytoplasmic turnover of the vast majority of proteins including regulatory proteins. We have synthesized lipopeptides a new class of non-covalent inhibitors of the 20S proteasome and assayed their inhibitory capacities. Their ability to inhibit at micromolar concentrations chymotrypsin-like and post-acid activities depends on peptide length (3 or 6 amino acids), sequence (presence of a positively or negatively charged amino acid), and alkyl chain length (C6-C18). These structural features could be varied to selectively inhibit one or more of the three proteasome activities.

MATERIALS
Product Number
Brand
Product Description

Supelco
Methyl palmitate, analytical standard
Sigma-Aldrich
Methyl palmitate, ≥97%
Sigma-Aldrich
Methyl palmitate, ≥99% (capillary GC)